- Home
- SABS vs JFU Comparison
SABS vs JFU Comparison
Compare SABS & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- JFU
- Stock Information
- Founded
- SABS 2014
- JFU 2006
- Country
- SABS United States
- JFU China
- Employees
- SABS N/A
- JFU N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- SABS Health Care
- JFU Finance
- Exchange
- SABS Nasdaq
- JFU Nasdaq
- Market Cap
- SABS 15.8M
- JFU 17.1M
- IPO Year
- SABS N/A
- JFU 2019
- Fundamental
- Price
- SABS $2.28
- JFU $2.51
- Analyst Decision
- SABS Strong Buy
- JFU
- Analyst Count
- SABS 5
- JFU 0
- Target Price
- SABS $10.00
- JFU N/A
- AVG Volume (30 Days)
- SABS 85.9K
- JFU 27.5K
- Earning Date
- SABS 11-05-2025
- JFU 01-01-0001
- Dividend Yield
- SABS N/A
- JFU N/A
- EPS Growth
- SABS N/A
- JFU N/A
- EPS
- SABS N/A
- JFU 0.58
- Revenue
- SABS $114,698.00
- JFU $42,467,427.00
- Revenue This Year
- SABS N/A
- JFU N/A
- Revenue Next Year
- SABS N/A
- JFU N/A
- P/E Ratio
- SABS N/A
- JFU $4.36
- Revenue Growth
- SABS N/A
- JFU N/A
- 52 Week Low
- SABS $1.00
- JFU $1.01
- 52 Week High
- SABS $6.60
- JFU $3.60
- Technical
- Relative Strength Index (RSI)
- SABS 54.42
- JFU 69.35
- Support Level
- SABS $2.03
- JFU $2.31
- Resistance Level
- SABS $2.34
- JFU $3.25
- Average True Range (ATR)
- SABS 0.12
- JFU 0.25
- MACD
- SABS 0.02
- JFU 0.02
- Stochastic Oscillator
- SABS 84.00
- JFU 47.52
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.